Nu-Med Plus (NUMD) Change in Accured Expenses (2012 - 2025)

Nu-Med Plus has disclosed Change in Accured Expenses across 14 years of filings, most recently posting $2625.0 for Q4 2025.

• Change in Accured Expenses for Q4 2025 came in at $2625.0, up 212.47% year-over-year; the trailing twelve-month figure through Dec 2025 was $3290.0 (down 62.27% YoY), and the FY2025 annual result was $3290.0, down 62.27% from the prior year.
• Change in Accured Expenses came in at $2625.0 for Q4 2025 at Nu-Med Plus, up from $1891.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $62945.0 in Q4 2022 to a low of -$6254.0 in Q2 2025.
• The 5-year median for Change in Accured Expenses is $4787.0 (2024), against an average of $9924.5.
• Across the five-year window, Change in Accured Expenses jumped 596.76% in 2021 and slumped 285.24% in 2024, its largest moves.
• Nu-Med Plus' Change in Accured Expenses stood at $21493.0 in 2021, then jumped by 192.86% to $62945.0 in 2022, then tumbled by 98.0% to $1260.0 in 2023, then plunged by 285.24% to -$2334.0 in 2024, then soared by 212.47% to $2625.0 in 2025.
• The last three Change in Accured Expenses figures came in at $2625.0 (Q4 2025), $1891.0 (Q3 2025), and -$6254.0 (Q2 2025), per Business Quant data.